Proteinase-activated receptor 2 (PAR-2) is a recently characterized G-protein coupled receptor that is cleaved and activated by pancreatic trypsin. Trypsin is usually considered a digestive enzyme in the intestinal lumen. We examined the hypothesis that trypsin, at concentrations normally present in the lumen of the small intestine, is also a signaling molecule that specifically regulates enterocytes by activating PAR-2. PAR-2 mRNA was highly expressed in the mucosa of the small intestine and in an enterocyte cell line. Immunoreactive PAR-2 was detected at the apical membrane of enterocytes, where it could be cleaved by luminal trypsin. Physiological concentrations of pancreatic trypsin and a peptide corresponding to the tethered ligand of PAR-2, which is exposed by trypsin cleavage, stimulated generation of inositol 1,4,5-trisphosphate, arachidonic acid release, and secretion of prostaglandin E 2 and F 1␣ from enterocytes and a transfected cell line. Application of trypsin to the apical membrane of enterocytes and to the mucosal surface of everted sacs of jejunum also stimulated prostaglandin E 2 secretion. Thus, luminal trypsin activates PAR-2 at the apical membrane of enterocytes to stimulate secretion of eicosanoids, which regulate multiple cell types in a paracrine and autocrine manner. We conclude that trypsin is a signaling molecule that specifically regulates enterocytes by triggering PAR-2.
Proteases in the intestinal lumen are traditionally considered digestive enzymes. Trypsin is one of the most important digestive proteases. Trypsinogen is a major component of pancreatic juice and, once activated in the intestinal lumen by enterokinase, trypsin digests dietary proteins and activates other zymogens. However, recent observations suggest that trypsin is a also a signaling molecule that specifically regulates cells by cleaving and triggering proteinase-activated receptor 2 (PAR-2) (1, 2).
The PARs are a new family of G-protein-coupled receptors for serine proteases. Thrombin activates PAR-1 and PAR-3 (3, 4) , and trypsin and mast cell tryptase activate PAR-2 (1, 5) . Proteases cleave within the extracellular N terminus of PARs, exposing tethered ligand domains that bind and activate the cleaved receptors. Synthetic peptides corresponding to the tethered ligands of PAR-1 and PAR-2 directly bind and activate the receptors and are useful reagents for investigating receptor functions without the use of proteases, which may have nonspecific effects (1, 3) .
PAR-1 and PAR-3 are expressed by platelets, fibroblasts, and endothelial cells, and mediate many of the effects of thrombin (3, 4, 6) . PAR-2 is expressed in the gastrointestinal tract, pancreas, kidney, liver, airway, ovary, and eye (1, 2) and is found in epithelial and endothelial cell lines, smooth muscle, T cell lines, and tumor cell lines (2, (7) (8) (9) (10) . The proteases that activate PAR-2 in these locations and the physiological function of PAR-2 are unknown. Trypsin in the intestinal lumen could activate PAR-2 if the receptor is expressed at the apical membrane of enterocytes. This may stimulate the secretion of eicosanoids, since trypsin induces prostaglandin (PG) secretion from hepatocytes (11) . Furthermore, PAR-1 activates cytoplasmic phospholipase A 2 (cPLA 2 ) and stimulates arachidonic acid release and PG secretion (12) (13) (14) (15) . Eicosanoids act locally in the intestinal wall to regulate epithelial transport, growth, and blood flow, and to mediate inflammation and cytoprotection (16) . Thus, luminal trypsin may influence multiple processes in the intestine through activation of PAR-2 and secretion of eicosanoids.
Trypsin at concentrations of Ͻ10 nM activates PAR-2 in transfected cells (2) , yet the concentration of trypsin in pancreatic juice and in the intestinal lumen of the rat is 1-40 M (17, 18). We hypothesized that trypsin, at concentrations normally present in the intestinal lumen, regulates enterocytes by activating PAR-2. The aims were to (i) localize PAR-2 in intestinal epithelium, (ii) determine if physiological concentrations of trypsin activate PAR-2 on enterocytes, and (iii) examine if this activation stimulates arachidonic acid release and PG secretion.
Northern Blot Analysis. Total RNA was extracted from rat intestinal mucosa (scraped from submucosa) and cell lines, separated on a 1.0% formaldehyde-agarose gel, transferred to nylon filters, and crosslinked. A 320-bp probe to transmembrane domain II and extracellular loop II of human PAR-2, and a 230-bp probe to the N terminus of rat PAR-2 were generated by PCR (2, 9) . Probes were labeled with [␣-32 P]dCTP and hybridized with filters (2) . Filters were also hybridized with a cDNA probe to ␤-actin. The intensity of hybridization was measured using a PhosphorImager (Molecular Dynamics).
Immunof luorescence. A polyclonal antiserum (B5) was raised in rabbits to a peptide corresponding to rat PAR-2 ( 30 GPNSKGR2SLIGRLDT 46 P-YGGC) coupled to keyhole limpet hemocyanin (2 trypsin cleavage site, YGGC for conjugation). An affinity-purified rabbit polyclonal antiserum (PAR-2C) to human PAR-2 (2 37 SLIGKVDGTSHVT-GKG 53 V) was from C. Derian (R. W. Johnson Pharmaceutical Research Institute, Spring House, PA). The molecular weight of PAR-2 is unknown, but human PAR-2 has a calculated mass of Ϸ44 kDa and one potential glycosylation site. Antisera recognized major proteins of Ϸ44 and Ϸ73 kDa on Western blots of KNRK-PAR-2 cells, and signals were suppressed by preabsorption with PAR-2 fragments (data not shown). Cells were fixed in 4% paraformaldehyde for 20 min at 4°C (21) . Rats fasted for 16 h were fixed by transcardial perfusion with paraformaldehyde (21) . PAR-2 was localized in 10-m frozen sections of small intestine, 5-m paraffin sections of hBRIE cells on filters, and KNRK-PAR-2 cells on coverslips by indirect immunofluorescence and confocal microscopy (21) .
InsP 3 Generation. InsP 3 was measured using a competitive binding assay (22) . hBRIE cells were preincubated with 10 mM LiCl for 10 min to prevent metabolism of InsP 3 . Results were calculated as pmols InsP 3 ͞10 6 cells. Arachidonic Acid Release. Cells were incubated in medium containing 10% serum and 0.5 Ci͞ml [ 3 H]arachidonic acid (180 Ci͞mmol, DuPont͞New England Nuclear; 1 Ci ϭ 37 GBq) for 6 h for KNRK-PAR-2 cells (57% incorporation of label) and 12 h for hBRIE cells (55% incorporation). Cells were incubated with agonists, and the medium was aspirated, centrifuged, and counted. PG Secretion. PGE 2 and PGF 1␣ secretion from cells was measured by RIA (DuPont͞New England Nuclear). Results were calculated as pg of PG secreted per 10 6 cells. PG secretion was measured from everted sacs of jejunum. Rats were fasted for 16 h and anesthetized with ketamine and xylazine (87 and 13 mg͞kg, i.m., respectively). To remove endogenous trypsin from the intestine, a catheter was placed into the bilepancreatic duct to divert secretion, and the duodenum and jejunum were perfused with NaCl containing 2 mg͞ml soybean trypsin inhibitor (SBTI) at 6 ml͞min for 2 h. Everted sacs (2 cm) of jejunum were prepared, ligated, washed, and incubated in 2 ml oxygenated Krebs buffer at 37°C. Tissue was incubated in buffer for 10 min, and agonists, or carrier (control) were added to the mucosal solution for 30 min. Basal PGE 2 secretion after 10 min and stimulated secretion after 30 min were measured in the mucosal solution. Results were calculated as PGE 2 secreted per gram of tissue.
Statistical Analyses. Observations on cell lines were made in duplicate from n Ͼ 3 experiments. Observations on rats were made on n Ͼ 3 animals. Results are expressed as mean Ϯ SE. Differences were examined by ANOVA and StudentNewman-Keuls test.
RESULTS
Expression of PAR-2 by Epithelial Cells. PAR-2 was expressed at very low levels by untransfected KNRK cells but was highly expressed by KNRK-PAR-2 and hBRIE cells (Fig. 1A) . PAR-2 was highly expressed at similar levels in duodenal, jejunal, ileal, and colonic mucosa (Fig. 1B) . A transcript of Ϸ3 kb, of similar size to that found in mouse and human (1, 2), was detected in cells and tissues.
Localization of PAR-2 in Epithelial Cells. Antisera to two different epitopes gave similar results. In KNRK-PAR-2 cells, PAR-2 was detected at the plasma membrane, in the Golgi apparatus, and in vesicles ( Fig. 2A , refs. 2 and 19). In hBRIE cells grown to confluence on filters, PAR-2 was detected at the apical and basolateral membrane, in the Golgi apparatus, and in vesicles (Fig. 2B ). PAR-2 was prominently localized to enterocytes of the villi and crypts of Lieberkühn of the small intestine, where it was present at the plasma membrane and in an intracellular compartment ( Fig. 2 C and E-G) . This compartment was stained with an antibody to mannosidase II, and is thus the Golgi apparatus (19) . PAR-2 was detected at the apical and basolateral membranes of enterocytes in the crypts ( Fig. 2 C and E) , and villi (Fig. 2 F and G) . PAR-2 was found at the plasma membrane of myocytes in muscularis externa and muscularis mucosa (Fig. 2H) . Staining was abolished by preabsorption of antisera with 1-10 M of the receptor fragments (Fig. 2D) .
InsP 3 Generation. Trypsin (Worthington) and activating peptide corresponding to the tethered ligand of rat PAR-2 (AP, SLIGRL-NH 2 ) stimulated InsP 3 generation in KNRK-PAR-2 and hBRIE cells, which peaked within 10 s (Fig. 3A) . Trypsin was considerably more potent and slightly more efficacious than AP, and trypsin that was inactivated by preincubation with 10 mg͞ml SBTI for 60 min and reverse peptide (RP, LRGILS-NH 2 ) had no effect ( Fig. 3 B and C) . Trypsin and AP had no effect in untransfected KNRK cells (Fig. 3 B and C) . The potency of trypsin was similar in KNRK-PAR-2 and hBRIE cells.
Arachidonic Acid Release. Trypsin and AP stimulated maximal release of radioactivity from KNRK-PAR-2 and hBRIE cells loaded with [ 3 H]arachidonic acid after 15 min (Fig. 4A) . Trypsin was more potent and efficacious than AP (Fig. 4 B and  C) . SBTI-treated trypsin and RP had no effect. The potency of trypsin was similar in KNRK-PAR-2 and hBRIE cells, and was comparable to the potency for stimulation of InsP 3 generation. (16) . Basal PGE 2 secretion was far higher from KNRK-PAR-2 than hBRIE cells, but trypsin and AP stimulated a greater fold increase in secretion from hBRIE cells. PGE 2 secretion was maximal at 5-15 min (Fig. 5A) , and trypsin was more potent and efficacious than AP (Fig. 5 B and  C) . SBTI-treated trypsin and RP had no effect. In untransfected KNRK cells, trypsin did not stimulate PGE 2 release except at high concentrations (10 M) and AP had no effect. The potency of trypsin was similar in KNRK-PAR-2 and hBRIE cells and was comparable to the potency for stimulation of InsP 3 generation and arachidonic acid release. In KNRK-PAR-2 cells, basal PGF 1␣ secretion (pg PGF 1␣ ͞10 Trypsin and AP were applied to the apical or basal surface of hBRIE cells on filters, and PGE 2 secretion was measured to provide functional evidence for localization of PAR-2 at the apical or basolateral membrane. Application of 100 nM trypsin or 100 M AP to the apical membrane for 30 min stimulated a Ͼ4-fold secretion of PGE 2 into the apical solution and a Ͼ2-fold secretion into the basal solution (Fig. 6) . Basal application of trypsin and AP stimulated a Ͼ2-fold increase in PGE 2 secretion into apical and basal solutions.
To determine if luminal trypsin stimulated PGE 2 secretion from the intact intestine, trypsin and AP were applied to the mucosal surface of everted sacs of jejunum and PGE 2 secretion into the mucosal solution was measured. Application of 10 M trypsin or 100 M AP to the mucosa for 30 min stimulated PGE 2 secretion by Ͼ7-fold and Ͼ3-fold over basal levels, respectively (Fig. 7) . SBTI-treated trypsin and RP had no effect.
DISCUSSION
Trypsin, at concentrations normally present in the intestinal lumen, activates PAR-2 at the apical membrane of enterocytes and stimulates the generation of eicosanoids, which may influence multiple functions of the intestine. Our results show that PAR-2 is highly expressed by enterocytes, where it is found at the apical and basolateral membranes. Trypsin activates PAR-2 in enterocytes to stimulate InsP 3 generation, arachidonic acid release, and PG secretion. PGs act in a paracrine and autocrine manner in the intestine to regulate multiple processes (16) . Thus, luminal trypsin is a signaling molecule that specifically regulates enterocytes by activating PAR-2.
Several observations indicate that PAR-2 is expressed by enterocytes. First, we detected abundant PAR-2 mRNA in the intestinal mucosa by Northern blot analysis. In support of this observation, we previously localized PAR-2 mRNA to enterocytes by in situ hybridization (2) . Second, we localized immunoreactive PAR-2 to the apical and basolateral membranes and the Golgi apparatus of enterocytes in the villi and crypts of small intestine. PAR-2 was also detected at the apical and basolateral membranes of hBRIE cells grown on filters under conditions that permit polarized growth and formation of tight junctions (20) , which we verified by microscopy. We have previously detected epitope-tagged PAR-2 at the plasma membrane and Golgi apparatus of KNRK-PAR-2 cells (2, 19) , which supports our current results. Staining of cells and tissues was abolished by preincubation of antisera with fragments used for immunization, confirming specificity. Luminal trypsin may activate PAR-2 at the apical membrane of enterocytes, or at the basolateral membrane if the epithelium is damaged. Trypsin induces internalization and degradation of PAR-2 in lysosomes, and the Golgi pool is required to replenish PAR-2 at the plasma membrane and permit cells to maintain responsiveness to repeated stimulation by trypsin (19) . The prominent Golgi store of PAR-2 may permit enterocytes to recover their capacity to respond to trypsin between meals. Finally, trypsin and AP stimulated InsP 3 generation, arachidonic acid release, and PG secretion from enterocytes, confirming expression of functional PAR-2. The findings that application of trypsin and AP to the apical membrane of hBRIE cells on filters and to mucosal surface of everted sacs of intestine stimulated PGE 2 secretion provides functional evidence for the presence of PAR-2 at the apical membrane of enterocytes.
Trypsin and AP stimulated InsP 3 generation, arachidonic acid release and PG secretion in KNRK-PAR-2 and hBRIE cells. Trypsin and AP mobilize Ca 2ϩ in many cell lines (2, 7, 8, 10) . In support of our results is the report that trypsin stimulates PG secretion from hepatocytes by a G-proteincoupled receptor (11) that is probably PAR-2. Activation of PAR-1 also stimulates arachidonic acid release and eicosanoid secretion (12) (13) (14) . The release of arachidonic acid is important because its availability is the rate-limiting step in eicosanoid generation (16) . PAR-2 may activate cPLA 2 , which releases arachidonic acid from membrane phospholipids. A Ca 2ϩ -dependent membrane-binding domain targets cPLA 2 to its substrates in the plasma membrane (14, 23) , and protein kinase C and mitogen-activated protein kinase phosphorylate and activate cPLA 2 (14, 24, 25) . PAR-2 increases intracellular Ca 2ϩ concentration and stimulates protein kinase C and mitogenactivated protein kinase in enterocytes (ref. 19 , N.W.B., unpublished data), suggesting a mechanism for the activation of cPLA 2 . The rapidity with which PG secretion follows activation of PAR-2 suggests that PG generation depends on cyclooxygenase 1, rather than inducible cyclooxygenase 2 (16) .
Several observations indicate that the responses to trypsin are mediated by PAR-2. First, trypsin did not stimulate InsP 3 generation or arachidonic acid release in untransfected KNRK cells. Only very high concentrations of trypsin stimulated PG secretion from these cells, probably due to the low levels of endogenous PAR-2 expression. Second, all of the effects of trypsin on cell lines and the everted sacs were mimicked by PAR-2 AP. We cannot be sure that AP only activates PAR-2, but it does not activate the PAR-1 (26) . Trypsin was usually more potent and efficacious than AP, as it is in other systems (1, 2). Thrombin is also more potent and sometimes more efficacious than peptides corresponding to the PAR-1-tethered ligand (3, 27) . The reason for these differences is not FIG. 6 . PGE2 secretion by hBRIE cells grown on filters. Trypsin, AP, or carrier (control) were applied to the apical or basal membranes. After 30 min, the apical and basal solutions were removed and PGE2 was measured. Results are expressed as pg PGE2 secreted per 10 6 cells (n ϭ 3 experiments). ‫ء‬ and #, P Ͻ 0.05 compared with apical and basal controls. The concentration of trypsin in pancreatic juice (Ϸ40 M) and intestinal fluid (Ϸ1-10 M) exceeds that required to activate PAR-2 in cell lines (Ϸ10 nM) (17, 18) . Higher trypsin concentrations (10 M) were required to stimulate PG secretion from everted sacs, although this is still in the physiological range. This may be due to the presence of mucus, which coats the epithelium and protects it from proteases. Thus, activation by trypsin may be more effective if the mucus layer is disrupted. The production of trypsin inhibitors, and the fact that PGs measured in the organ bath probably underestimate concentrations in the extracellular fluid, may also explain the lack of effects of lower trypsin concentrations.
PAR-2 was also detected at the basolateral membranes of enterocytes and in myocytes. PAR-2 is also expressed in gastric muscle (9) . Enzymes other than trypsin probably activate PAR-2 in these locations. One possibility is mast cell tryptase, which activates PAR-2 in several cell types, including enterocytes and myocytes (ref. 5 , N.W.B., unpublished data). Mast cells containing tryptase are normally found in the intestine, and their number increases during inflammation (29) , suggesting that PAR-2 mediates some effects of mast cell proteases. PAR-2 is up-regulated by interleukin 1␣ and tumor necrosis factor, supporting its role in inflammation (30) .
We conclude that pancreatic trypsin activates PAR-2 at the apical membrane of enterocytes and regulates the intestinal epithelium. Thus, in addition to its digestive function, trypsin should also be considered an intestinal signaling molecule that specifically regulates enterocytes through PAR-2.
